Formas seudotumorales de esclerosis múltiple. A propósito de 3 observaciones clínicas

Oehninger Gatti, Carlos L; Buzó del Puerto, Ricardo M; Gómez Añón, A; Alcántara Pelaez, Juan Carlos; García, M; Fojgiel Lipowicz, Laura A.
Arch. Inst. Neurol ; 7: 13-6, 2004. ilus
Artículo en Español | BVSNACUY | ID: bnu-12600

Documentos relacionados

  1. Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial.
  2. [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].
  3. [Assessment of compliance and patient pathway among multiple sclerosis patients on disease modifying treatment].
  4. [Effective therapy in highly active pediatric multiple sclerosis].
  5. Recent advances in network medicine: From disease mechanisms to new treatment strategies.
  6. Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis.
  7. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
  8. [The effect of fampridine on gait in people with Multiple sclerosis (MS)].
  9. [Pregnancy and breastfeeding in women with multiple sclerosis].
  10. [May neuroimaging findings of a child with multiple sclerosis surprise us? Clinical and radiological observation].